Tag: cancer genetics
January 29, 2019
Cancer Genetics Announces Pricing of $3.5 Million Public Offering of Common Stock
Cancer Genetics (Nasdaq:CGIX), a leader in enabling precision medicine for immuno-oncology and genomic medicine through molecular markers and diagnostics, today... December 17, 2018
Cancer Genetics Terminates Proposed Merger with NovellusDx
Cancer Genetics (Nasdaq:CGIX), a leader in enabling precision medicine for immuno-oncology and genomic medicine through molecular markers and diagnostics, today...
October 18, 2018
Cancer Genetics and Genecast Partner on Gene Test
Cancer Genetics announced on Thursday that it has partnered with China-based Genecast Biotechnology to market, distribute and sell the Tissue... October 18, 2018
Cancer Genetics Enters Strategic Partnership with Genecast Biotechnology to Commercialize Tissue of Origin Test in China
Cancer Genetics (Nasdaq:CGIX) a leader in enabling precision medicine for immuno-oncology and genomics through molecular markers and diagnostics, today announced...
October 3, 2018
VIDEO — Life Science Update September 2018
With September officially behind us, the Investing News Network is taking a look back at some of the biggest news...
September 18, 2018
Cancer Genetics Merges with NovellusDx
Two companies with similar oncology goals, Cancer Genetics and NovellusDx, have signed a definitive merger agreement, announced Tuesday. September 18, 2018